Pleomorphic lobular carcinoma of the breast: a comparison of cytopathological features with other lobular carcinoma variants

被引:10
|
作者
Ohashi, R. [1 ]
Matsubara, M. [1 ]
Watarai, Y. [1 ]
Yanagihara, K. [2 ]
Yamashita, K. [2 ]
Tsuchiya, S. -I. [1 ,3 ]
Takei, H. [2 ]
Naito, Z. [1 ,4 ]
机构
[1] Nippon Med Coll Hosp, Dept Diagnost Pathol, Tokyo, Japan
[2] Nippon Med Coll Hosp, Dept Breast Surg, Tokyo, Japan
[3] Iida Hosp, Dept Diagnost Pathol, Tokyo, Japan
[4] Nippon Med Sch, Dept Integrated Diagnost Pathol, Tokyo, Japan
关键词
pleomorphic lobular carcinoma; fine needle aspiration; cytology; FINE-NEEDLE-ASPIRATION; INVASIVE DUCTAL CARCINOMAS; OF-THE-LITERATURE; CYTOLOGIC DIAGNOSIS; IN-SITU; CANCER; EXPRESSION; EXPERIENCE; PITFALL; BIOPSY;
D O I
10.1111/cyt.12362
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective: Pleomorphic lobular carcinoma (PLC) is a subtype of breast cancer with unique morphological features, but it remains controversial whether PLC should be considered an independent disease entity. The aim of this study was to illustrate cytopathological characteristics of PLC in comparison with other lobular carcinoma variants. Methods: We investigated clinicopathological features of PLC (n = 11) compared with those of other variants of invasive lobular carcinoma (ILC, non-PLC) (n = 32). Histological variants of the non-PLC group consisted of classic (n = 25), solid (n = 2), alveolar (n = 1) and a tubulolobular type (n = 4). A review of cytological reports and fine needle aspiration (FNA) smear samples was performed for the PLC (n = 9) and non-PLC (n = 27) groups. Results: : Patients with PLC were older, and had a higher nuclear grade and a higher incidence of axillary lymph node metastasis and triple negative phenotype than non-PLC patients (P = 0.007, P < 0.001, P = 0.02 and P < 0.001, respectively). Cytological findings in PLC included medium-to large-sized nuclei, prominent nucleoli, a moderate-to-severe degree of pleomorphism, apocrine change and background necrosis, none of which were evident in the smears of the non-PLC group (P < 0.001, P = 0.002, P < 0.001, P < 0.001, and P = 0.03, respectively). Despite these differences, patients with PLC and non-PLC showed similar clinical outcomes in our follow-up period. Conclusions: Based on our results, a cytological diagnosis of PLC should be proposed if there are moderate-to large-sized nuclei, prominent nucleoli, a moderate-to severe degree of nuclear pleomorphism, apocrine change and necrosis in the background in FNA biopsy samples.
引用
收藏
页码:122 / 130
页数:9
相关论文
共 50 条
  • [21] Comparison of Invasive Pleomorphic Lobular Carcinoma With Invasive Classic Lobular Carcinoma: Clinicopathologic and Biomarker Analysis
    Harbhajanka, Aparna
    Lambzabi, Ihab
    Syed, Sahr
    Jain, Richa
    Reddy, Vijaya
    Ghai, Ritu
    Bitterman, Pincas
    Mei, Mariachiara
    Gattuso, Paolo
    MODERN PATHOLOGY, 2015, 28 : 48A - 48A
  • [22] Comparison of Invasive Pleomorphic Lobular Carcinoma With Invasive Classic Lobular Carcinoma: Clinicopathologic and Biomarker Analysis
    Harbhajanka, Aparna
    Lambzabi, Ihab
    Syed, Sahr
    Juin, Richa
    Reddy, Vijaya
    Ghai, Ritu
    Bitterman, Pincas
    Mei, Mariachiara
    Gattuso, Paolo
    LABORATORY INVESTIGATION, 2015, 95 : 48A - 48A
  • [23] Claudin Expression in Invasive Lobular Carcinoma with an Emphasis on Pleomorphic Lobular Carcinoma
    Lu, S.
    Singh, K.
    Mangray, S.
    Tavares, R.
    Monahan, R.
    Li, J.
    Resnick, M.
    Yakirevich, E.
    MODERN PATHOLOGY, 2012, 25 : 52A - 52A
  • [24] Claudin Expression in Invasive Lobular Carcinoma with an Emphasis on Pleomorphic Lobular Carcinoma
    Lu, S.
    Singh, K.
    Mangray, S.
    Tavares, R.
    Monahan, R.
    Li, J.
    Resnick, M.
    Yakirevich, E.
    LABORATORY INVESTIGATION, 2012, 92 : 52A - 52A
  • [25] Pleomorphic invasive lobular breast carcinoma: Prognosis and characteristics compared with classical invasive lobular breast carcinoma.
    Choi, Christine H.
    Liu, Ying
    Kalinsky, Kevin
    Connolly, Eileen
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] Pleomorphic lobular carcinoma in situ
    King, Tari A.
    Reis-Filho, Jorge S.
    BREAST CANCER MANAGEMENT, 2013, 2 (05) : 375 - 384
  • [27] LOBULAR CARCINOMA OF THE BREAST WITH SECRETORY FEATURES
    GOULD, VE
    CHEJFEC, G
    ULTRASTRUCTURAL PATHOLOGY, 1980, 1 (01) : 151 - 156
  • [28] Multiphoton imaging of normal breast lobules, pleomorphic invasive lobular carcinoma, and classic invasive lobular carcinoma
    He, Jiajia
    Shen, Tingfeng
    Kang, Deyong
    Wang, Shu
    Guo, Wenhui
    Li, Lianhuang
    Zheng, Liqin
    Wang, Chuan
    Chen, Jianxin
    OPTICS IN HEALTH CARE AND BIOMEDICAL OPTICS IX, 2020, 11190
  • [29] Treatment Outcomes for Pleomorphic Lobular Carcinoma In Situ of the Breast
    Desai, Amita A.
    Jimenez, Rafael E.
    Hoskin, Tanya L.
    Day, Courtney N.
    Boughey, Judy C.
    Hieken, Tina J.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (10) : 3064 - 3068
  • [30] Invasive Pleomorphic Lobular Carcinoma of the breast: Clinicopathological features, treatment patterns and outcomes
    Peradze, N.
    Polizzi, A.
    Pagan, E.
    Bottazzoli, E.
    Bagnardi, V
    Sangalli, C.
    Morigi, C.
    De Camili, E.
    Raviele, P. Rafaniello
    Corso, G.
    Galimberti, V
    Colleoni, M.
    Veronesi, P.
    EJSO, 2025, 51 (06):